Reading; Through the Eyes of a University Student
Launched by UNIVERSITY OF ULSTER · Mar 20, 2020
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The participants will be recruited from the undergraduate Ulster University student population. Those students who have been identified as potentially having visual stress will be invited to undergo screening tests to assess their eligibility to participate in the randomized controlled trial.
Visit 1:
Each consenting participant will undergo tests to assess their eligibility to participate in this study.
Provided the participant meets the inclusion criteria then they will undergo a baseline eye examination and reading tests including the Wilkins Rate of Reading test (WRRT).
The particip...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consenting undergraduate University students, studying at Ulster University who have visual stress symptoms.
- Exclusion Criteria:
- • Reduced visual acuity
- • Uncorrected spectacle prescription
- • Decompensating heterophoria
- • Heterotropia
- • Accommodative insufficiency
- • Convergence insufficiency
- • Ocular health abnormality
- • Any participant currently using precision tinted lenses
About University Of Ulster
The University of Ulster is a leading academic institution dedicated to advancing knowledge and innovation through research and education. Renowned for its commitment to excellence, the university actively engages in clinical trials aimed at improving healthcare outcomes and addressing pressing health challenges. With a robust infrastructure for research and a multidisciplinary approach, the University of Ulster fosters collaboration among researchers, healthcare professionals, and industry partners. Its focus on evidence-based practices ensures that clinical trials are designed and conducted to the highest ethical and scientific standards, contributing valuable insights to the field of medicine and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coleraine, Londonderry, United Kingdom
Coleraine, Londonderry, United Kingdom
Patients applied
Trial Officials
Sara McCullough, PhD
Principal Investigator
Ulster University
Julie-Anne Little, PhD
Study Director
Ulster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials